Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 258,427 | 230,269 | 233,487 | 210,830 | 201,461 |
| Cost of Goods | 30,799 | 39,952 | 37,795 | 31,443 | 31,744 |
| Gross Profit | 227,628 | 190,317 | 195,692 | 179,387 | 169,717 |
| Operating Expenses | 335,260 | 322,624 | 407,619 | 266,711 | 276,274 |
| Operating Income | -106,833 | -131,355 | -211,132 | -86,881 | -105,813 |
| Other Income | 5,527 | -125,063 | -16,961 | -17,265 | -16,076 |
| Pre-tax Income | -101,306 | -256,418 | -228,093 | -104,146 | -121,889 |
| Income Tax | 7,938 | 1,320 | 3,388 | 879 | 92 |
| Net Income Continuous | -109,244 | -257,738 | -231,481 | -105,025 | -121,981 |
| Net Income | $-109,244 | $-257,738 | $-231,481 | $-105,025 | $-121,981 |
| EPS Basic Total Ops | -1.24 | -2.94 | -2.65 | -1.20 | -1.43 |
| EPS Basic Continuous Ops | -1.24 | -2.94 | -2.65 | -1.20 | -1.43 |
| EPS Diluted Total Ops | -1.24 | -2.94 | -2.65 | -1.20 | -1.43 |
| EPS Diluted Continuous Ops | -1.24 | -2.94 | -2.65 | -1.20 | -1.43 |
| EPS Diluted Before Non-Recurring Items | -1.24 | -2.94 | -2.65 | -1.20 | N/A |
| EBITDA(a) | $-102,413 | $-123,711 | $-202,652 | $-76,212 | $-95,770 |